The Venture Codex Logo

The Venture Codex

Overview

Oncology therapeutics development for cancer treatment.

Total Raised

$407 M

Rounds

4

Links

Verticals

Biotechnology
Health Care
Medical
Oncology
Therapeutics

Investment History

  1. Series B

    Sep 2025

    $60M

  2. Series A

    Mar 2024

    $150M

  3. Equity

    May 2023

    $197M

Team

Athena Countouriotis

CEO

Mohammad Hirmand

CMO

Scott Lipman

CBO

Brian Sun

Legal